Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Free Report) – Stock analysts at Roth Capital decreased their Q1 2025 earnings estimates for Bioceres Crop Solutions in a research report issued to clients and investors on Wednesday, September 11th. Roth Capital analyst S. Fortune now anticipates that the company will earn $0.04 per share for the quarter, down from their prior estimate of $0.21. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.81 per share. Roth Capital also issued estimates for Bioceres Crop Solutions’ Q2 2025 earnings at $0.09 EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at $0.13 EPS, FY2025 earnings at $0.25 EPS and FY2026 earnings at $0.63 EPS.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last posted its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The business had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. During the same period last year, the company earned ($0.06) EPS.
Check Out Our Latest Analysis on Bioceres Crop Solutions
Bioceres Crop Solutions Stock Performance
NASDAQ:BIOX opened at $8.56 on Friday. Bioceres Crop Solutions has a 12-month low of $8.16 and a 12-month high of $14.05. The company has a quick ratio of 0.83, a current ratio of 1.28 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $537.57 million, a PE ratio of 856.00 and a beta of 0.49. The firm has a 50-day moving average price of $10.43 and a 200 day moving average price of $11.41.
Hedge Funds Weigh In On Bioceres Crop Solutions
Several large investors have recently bought and sold shares of BIOX. Cape Investment Advisory Inc. acquired a new position in Bioceres Crop Solutions in the fourth quarter valued at approximately $33,000. Wellington Management Group LLP lifted its holdings in Bioceres Crop Solutions by 3.1% in the fourth quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock valued at $3,253,000 after buying an additional 7,096 shares during the period. Fourth Sail Capital LP raised its holdings in Bioceres Crop Solutions by 136.1% in the first quarter. Fourth Sail Capital LP now owns 1,627,630 shares of the company’s stock worth $20,606,000 after purchasing an additional 938,282 shares during the period. Activest Wealth Management acquired a new stake in Bioceres Crop Solutions in the first quarter worth $30,000. Finally, Oppenheimer & Co. Inc. acquired a new stake in Bioceres Crop Solutions in the first quarter worth $139,000. 17.68% of the stock is currently owned by institutional investors and hedge funds.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
See Also
- Five stocks we like better than Bioceres Crop Solutions
- Where to Find Earnings Call Transcripts
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- What is a buyback in stocks? A comprehensive guide for investors
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- Business Services Stocks Investing
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.